Efficacy and Safety Aiming at the Combined-Modality Therapy of External Beam Radiotherapy (40Gy) and Iodine-125 Seed Implantation for Locally Advanced NSCLC in the Elderly
Open Access
- 1 July 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Management and Research
- Vol. ume 13, 5457-5466
- https://doi.org/10.2147/cmar.s294313
Abstract
Purpose: To evaluate the efficacy and safety of combined-modality therapy for elderly patients with locally advanced non-small-cell lung cancer (NSCLC) invading the chest wall. Patients and Methods: We retrospectively enrolled 21 elderly patients (aged ≥ 60 years) with locally advanced NSCLC invading the chest wall. For external beam radiotherapy (EBRT) of the primary tumor, 40Gy was applied and supplemented with iodine-125 seed implantation while 60Gy was applied to the lymph nodes of the mediastinum. Follow-up was conducted every 3 months postoperatively. The related analytic parameters were change in tumor size, the objective response rate (ORR), the disease control rate (DCR), the degree of pain relief, the improvement of physical status, and toxicity. Results: The combined-modality therapy significantly inhibited local growth of the tumor (from 7.84± 1.20 to 4.69± 1.90 cm) (P < 0.0001), with 71.4% ORR and 90.5% DCR at 1 year. The cancer-related pain was significantly relieved (P < 0.05) and physical status was significantly improved (P < 0.05). No procedure-associated death or grade > 2 irradiation-related adverse effects were reported in this study. Conclusion: The combined-modality therapy of EBRT with 40Gy and permanent iodine-125 seed implantation is an efficacious and safe treatment option for elderly patients with locally advanced NSCLC invading the chest wall.Keywords
This publication has 40 references indexed in Scilit:
- Palliative endobronchial brachytherapy for non-small cell lung cancerEmergencias, 2012
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI Journal of the National Cancer Institute, 2011
- Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) DatabaseClinical Lung Cancer, 2011
- Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy AgencyEndocrine, 2011
- Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation DocetaxelEndocrine, 2010
- Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidityAnnals of Oncology, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Lung Cancer Invading the Chest Wall: A Plea for En-Bloc Resection but the Need for New Treatment StrategiesThe Annals of Thoracic Surgery, 2005
- Resection of chest wall invasion in patients with non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2004